Businnes Worldwide Magazine interviews NLS Pharma's CEO Alex Zwyer
Conditions like Attention Deficit Hyperactivity Disorder are costly both to individuals and society. We talk to Alex Zwyer, CEO of NLS-1 Pharma AG (NLS), a cutting-edge biotech company, about their novel treatments for ADHD and what makes their company so great at innovation.


